Pros/cons of ozempic


Based on the information retrieved from Huberman Lab, we can discuss GLP-1 agonists like semaglutide, which has a brand name Ozempic, used for weight loss. Peter Attia and Andrew Huberman have discussed the potential of these drugs as a treatment for obesity. They noted that while GLP-1 agonists are considered to be safer than previous drugs like fenfen, they also present their own issues, such as being catabolic across the board, which means they can lead to a generalized breakdown of body tissues 1.

The discussion between Attia and Huberman included semaglutide specifically, acknowledging its effectivity for weight loss and touching upon dosage and potential impacts on the body. This recognition of its benefits, however, does not include a comprehensive analysis of all pros and cons.

Although there were other relevant discussions on drug effects, such as the side effects of statins and oral contraceptives, and the benefits of specific supplements, these do not provide a complete picture of the pros and cons of Ozempic 2.

To dive deeper into the specific pros and cons of Ozempic, it would be beneficial to consult more specialized medical sources or speak to healthcare professionals, as the clips retrieved from the Huberman Lab do not cover the full range of pros and cons for Ozempic.

GLP-1 Agonists

Peter Attia and Andrew Huberman discuss the potential of GLP-1 agonists as a blockbuster obesity drug. While safer than fenfen, these drugs come with their own set of problems, such as being catabolic across the board. Despite this, Attia is excited about them and sees them as just the tip of the iceberg.

Huberman Lab

Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85